/ /

Mohammad Rafieetary, OD, FAAO
Dr. Mohammad Rafieetary is a consultative optometric physician at the Charles Retina Institute in Memphis. He is a fellow of the American Academy of Optometry and a Diplomate of the American Board of Optometry as well as the American Board of Certification in Medical Optometry. He has received numerous awards including Tennessee Optometrist of the Year and the National American Diabetes Association Award of the Achievement of Distinction. Dr. Rafieetary has numerous publications and lectures with the emphasis on posterior segment disease. E-mail him at mrafieetary@charles-retina.com.
Acute viral maculopathy linked with hand, foot, and mouth disease
The patient noticed the symptoms while suffering from fever secondary to hand, foot, and mouth disease.
Misdiagnosing macular degeneration
A number of macular conditions either mimic or share characteristic findings of age-related macular degeneration (AMD). These resemblances can result in tough clinical decisions and misdiagnosis. Although genetic testing can be helpful, tests are limited by both their efficacy and accuracy.
What we can learn from managing diabetic patients
What we can learn from managing diabetic patients
Many diabetics neglect their eyecare due to not knowing and/or misunderstanding the effects of diabetes to the eyes and visual system. Much of the inadequacies in patient education can be attributed to the absence or insufficient communication among healthcare providers, including optometrists, and our patients.
A clinical perspective of neovascular glaucoma
Neovascular glaucoma is a potentially devastating ocular consequence of pathologic neovascularization of intraocular tissue. The symptoms include vision loss caused by both the underlying etiology (such as retinal vascular disease) as well as increased intraocular pressure (IOP), often accompanied by corneal edema, hyphema, or vitreous hemorrhage.
Retinal vascular disease and its underlying etiology
Retinal vaso-occlusive disorders are common causes of vision loss and blindness in the world. Diabetic retinopathy, the most prevalent retinal vascular disease, is a leading cause of blindness in patients between 20 to 74 years of age in the U.S.